Granted Patent
B2
US 7,781,396 · App. 11/471,657 · Granted Aug 24, 2010
Peptides directed for diagnosis and treatment of amyloid-associated disease
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Peptides having at least 2 amino acids and no more than 15 amino acids are provided. The peptides comprise amino acid sequence X-Y or Y-X, wherein X is an aromatic amino acid and Y is any amino acid other than glycine. Also provided are pharmaceutical compositions and kits including such peptides as well as methods using same for diagnosing and treating amyloid associated diseases.
Claims (2)
1. A synthetic dipeptide as set forth in SEQ ID NO: 145 (D-Trp-Aib).
2. A pharmaceutical composition comprising as an active ingredient a synthetic dipeptide as set forth in SEQ ID NO: 145 (D-Trp-Aib) and a pharmaceutically acceptable carrier or diluent.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 21, 2006
From: GAZIT, EHUD
To: TEL AVIV UNIVERSITY FUTURE TECHNOLOGY DEVELOPMENT L.P.
Reel/Frame 018032/0148 →
Continuity (10)
Continuation In Part
1056285200
Continuation In Part
PCTIL0300007900
· Jan 30, 2003
Provisional Application
6048318000
· Jun 30, 2003
Provisional Application
6051497400
· Oct 29, 2003
Provisional Application
6035257800
· Jan 31, 2002
Provisional Application
6039226600
· Jul 1, 2002
Provisional Application
6043645300
· Dec 27, 2002